RadNet (RadNet) Debt-to-Equity

: 2.36 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

RadNet's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $74 Mil. RadNet's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1,417 Mil. RadNet's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $631 Mil. RadNet's debt to equity for the quarter that ended in Dec. 2023 was 2.36.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for RadNet's Debt-to-Equity or its related term are showing as below:

RDNT' s Debt-to-Equity Range Over the Past 10 Years
Min: 2.36 Med: 7.47 Max: 111.45
Current: 2.36

During the past 13 years, the highest Debt-to-Equity Ratio of RadNet was 111.45. The lowest was 2.36. And the median was 7.47.

RDNT's Debt-to-Equity is ranked worse than
96.95% of 197 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs RDNT: 2.36

RadNet Debt-to-Equity Historical Data

The historical data trend for RadNet's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RadNet Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

7.79

7.15

6.11

4.55

2.36

RadNet Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity																4.55	4.73	2.62	2.48	2.36

Competitive Comparison

For the Diagnostics & Research subindustry, RadNet's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RadNet Debt-to-Equity Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, RadNet's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where RadNet's Debt-to-Equity falls into.

RadNet Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

RadNet's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(73.955	+	1417.165)	/	630.695
	=	2.36

RadNet's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(73.955	+	1417.165)	/	630.695
	=	2.36

RadNet (NAS:RDNT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

RadNet Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of RadNet's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

RadNet (RadNet) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RadNet Inc (NAS:RDNT) » Definitions » Debt-to-Equity

Comparable Companies

NEOG SHC GH NEO TWST MYGN VCYT OPK LAB FLGT TSE:2309 TMO DHR IQV IDXX XSWX:LONN A MTD ICLR ILMN

Traded in Other Exchanges

PQIA:Germany

Address

1510 Cotner Avenue, Los Angeles, CA, USA, 90025

Website

http://www.radnet.com

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.

Executives

Michael N Murdock	officer: Executive Vice President	3600 JP MORGAN CHASE TOWER, 2200 ROSS AVENUE, DALLAS TX 752012776
Christine Nayoma Gordon	director	3081 PANAMA AVE., CARMICHAEL CA 95608
Gregory Sorensen	director, officer: EVP Chief Science Officer	C/O DFB HEALTHCARE ACQUISITIONS CORP, 780 THIRD AVENUE, NEW YORK NY 10017
Norman R Hames	director, officer: Vice President
Stephen M Forthuber	officer: Executive Vice President	3600 JP MORGAN CHASE TOWER, 2200 ROSS AVENUE, DALLAS TX 75201-2776
Ruth Louisa Villigerwilson	director, officer: Senior Vice President	3700 WALNUT AVENUE, LONG BEACH CA 90801
David L Swartz	director	1510 COTNER AVENUE, LOS ANGELES CA 90025
Gregory E. Spurlock	director	4116 E. NORTHRIDGE CIRCLE, MESA AZ 85215-9807
John V Crues	director	1510 COTNER AVE, LOS ANGELES CA 90025
Lawrence L Levitt	director	2934 1/2 BEVERLY GLEN CIRCLE #325, LOS ANGELES CA 90077
Ranjan Jayanathan	officer: Chief Information Officer	13388 HUNT RIDGE ROAD, ELLICOTT CITY MD 21042
Laura Pastre Jacobs	director	10154 BRIDLEVALE DRIVE, LOS ANGELES CA 90064
Karen B. Kaplan Survivor's Trust	other: Indirect owner	10776 WILSHIRE BLVD/, LOS ANGELES CA 90024-6447
David Jeffrey Katz	officer: EVP and General Counsel	1510 COTNER AVE, LOS ANGELES CA 90025
Sherman Michael L Md	director